Dimensional Fund Advisors’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Dimensional Fund Advisors’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-112,646	Closed	-$487K	–	3412
2019 Q3	$487K	Sell	112,646 -66,993	-37%	-$268K	﹤0.01%	3145
2019 Q2	$717K	Sell	179,639 -10,762	-6%	-$51.2K	﹤0.01%	3123
2019 Q1	$1.02M	Sell	190,401 -1,378	-0.7%	-$8.9K	﹤0.01%	3030
2018 Q4	$984K	Hold	191,779	–	–	﹤0.01%	3014
2018 Q3	$1.86M	Buy	+191,779	New	+$1.93M	﹤0.01%	2943
2015 Q3	–	Sell	-29,363	Closed	-$757K	–	3376
2015 Q2	$757K	Sell	29,363 -366	-1%	-$10.4K	﹤0.01%	3072
2015 Q1	$929K	Sell	29,729 -7,816	-21%	-$224K	﹤0.01%	3001
2014 Q4	$1.45M	Sell	37,545 -1,336	-3%	-$31.9K	﹤0.01%	2930
2014 Q3	$945K	Hold	38,881	–	–	﹤0.01%	3021
2014 Q2	$928K	Sell	38,881 -343	-0.9%	-$11.2K	﹤0.01%	3052
2014 Q1	$1.45M	Hold	39,224	–	–	﹤0.01%	2936
2013 Q4	$1.58M	Sell	39,224 -341	-0.9%	-$14.5K	﹤0.01%	2906
2013 Q3	$1.51M	Sell	39,565 -113	-0.3%	-$4.05K	﹤0.01%	2942
2013 Q2	$1.44M	Buy	+39,678	New	+$1.7M	﹤0.01%	2920

Other funds holding PRTK

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

APCM

Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's PRTK Position: Q4 2019 in Review

Dimensional Fund Advisors sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q4 2019, closing a stake of 112,646 shares — an estimated $487K sold.

Dimensional Fund Advisors first reported a position in PRTK in Q2 2013 and held it in 14 quarters. The position peaked at $1.86M in Q3 2018. 93 funds tracked by Wall St. Rank hold PRTK as of Q4 2019.

Dimensional Fund Advisors reported no remaining Paratek Pharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Dimensional Fund Advisors sold 112,646 Paratek Pharmaceuticals, Inc. shares in Q4 2019, an estimated $487K.
Dimensional Fund Advisors first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
Dimensional Fund Advisors's Paratek Pharmaceuticals, Inc. position peaked at $1.86M in Q3 2018.
93 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q4 2019.

Based on Dimensional Fund Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.